Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 14, 2024.
All times in Eastern Daylight Time.
-
Rubisco Seeds introduces the first commercial High Oleic, Low Linolenic (HOLL) winter canola to the US marketPHILPOT, Ky.--(BUSINESS WIRE)--Continuing its tradition of supplying high productivity non-GMO winter canola hybrids to farmers over two decades, Rubisco Seeds’ recent introduction of Winter HOLL f... more »
-
PACS Group, Inc. Reports First Quarter 2024 ResultsFARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United ... more »
-
Pint Pharma anuncia a aprovação de ORLADEYO® (berotralstate), primeira terapia oral, indicada como prevenção das crises de angioedema hereditário (AEH) em adultos e pacientes pediátricos com 12 anos ou mais no MexicoCidade do México--(BUSINESS WIRE)--É com grande prazer que anunciamos que a Comissão Federal para a Proteção contra Riscos de Saúde (COFEPRIS) no México concedeu aprovação para o ORLADEYO® (berotra... more »
-
Pint Pharma anuncia la aprobación de ORLADEYO® (berotralstat), la primera terapia oral indicada para prevenir los ataques de angioedema hereditario (HAE) en pacientes adultos y pediátricos de 12 años en adelante en Mexico.Ciudad de México--(BUSINESS WIRE)--Es un gran placer anunciar que la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) en México ha aprobado el uso oral diario de ORLADEYO® (... more »
-
Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in MexicoMEXICO CITY--(BUSINESS WIRE)--It is with great pleasure that we announce the Federal Commission for Protection against Health Risks (COFEPRIS) in Mexico has granted approval for oral, once-daily OR... more »
-
KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2024-CES4 (RCKT 2024-CES4)NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 16 classes of mortgage-backed notes from RCKT Mortgage Trust 2024-CES4 (RCKT 2024-CES4), $445.0 million RMBS transaction, as of the cu... more »
-
NEW YORK--(BUSINESS WIRE)--Institutional investor and union pension fund Plaintiff Michiana Area Electrical Workers’ Pension Fund filed a class action lawsuit today against Inari Medical, Inc. (“In... more »
-
LOS ANGELES--(BUSINESS WIRE)--Learn CW Investment Corporation (the “Company,” “we” or “our”), a special purpose acquisition company, announced today that it has further extended the period of time ... more »
-
Exchange Income Corporation Announces Voting Results for its 2024 Annual and Special Meeting of ShareholdersWINNIPEG, Manitoba--(BUSINESS WIRE)--Exchange Income Corporation Announces Voting Results for its 2024 Annual and Special Meeting of Shareholders more »
-
Kirby McInerney LLP Reminds Exscientia p.l.c. (EXAI) Investors of Class Action Filing and Encourages Investors to Contact the FirmNEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of th... more »
-
EVLV INVESTOR ALERT: Kirby McInerney LLP Notifies Evolv Technologies Holdings, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitNEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP notifies investors of the fast-approaching May 24, 2024 deadline to apply for lead plaintiff in a federal securities class action that... more »
-
Kirby McInerney LLP Reminds Globe Life Inc. (GL) Investors of Class Action Filing and Encourages Investors to Contact the FirmNEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on behalf of those w... more »
-
Cessna Citation Ascend Programm kommt mit erfolgreichen Zertifizierungstests und umfangreichen Flugtests voranWICHITA, Kansas--(BUSINESS WIRE)--Textron Aviation gab heute den weiteren Fortschritt des Cessna Citation Ascend-Programms bekannt, nachdem das Prototyp-Flugzeug zahlreiche Zertifizierungstests und... more »
-
Pembina Pipeline Corporation Announces Renewal of Share Repurchase ProgramCALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) announced today that the Toronto Stock Exchange (the "TSX") has approved the renew... more »
-
BLUE INVESTOR ALERT: Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitNEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP notifies investors of the approaching May 28, 2024 deadline to seek the role of lead plaintiff in a federal securities class action fi... more »